A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT06212245 · UNKNOWN
Trial details
- NCT number
- NCT06212245
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-25
- Primary completion
- 2024-12-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.